13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001801265
Total reported value
$2.3B
$2.3B
26 檔
36.6%
According to the latest 13F quarterly dataset, Madison Avenue Partners, LP managed an equity portfolio of $2.3B at the end of Q2 2025, spanning 26 distinct U.S. exchange-listed positions.
Madison Avenue Partners, LP executed strategic sector rebalancing during Q2 2025, establishing 8 new positions while fully exiting 4 holdings and trimming 8 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GHC | Graham Holdings Co-class B | Stock-Industrials | 15.49% | +0.81% | — | |
| 2 | SOLV | Solventum CORP | Stock-Healthcare | 11.36% | +0.45% | -20.22% | |
| 3 | MKL | Markel Group Inc | Stock-Financials | 11.24% | +2.12% | -7.71% | |
| 4 | SNDK | Sandisk CORP | Stock-Tech | 10.81% | -16.15% | — | |
| 5 | INDV | Indivior Pharmaceuticals, Inc. | Stock-Other | 7.80% | — | +1.67% | |
| 6 | TBPH | Theravance Biopharma, Inc. | Stock-Other | 7.00% | +0.03% | — | |
| 7 | GMED | Globus Medical Inc - A | Stock-Healthcare | 6.75% | +0.49% | — | |
| 8 | WLY | Wiley (john) & Sons-class A | Stock-Other | 6.12% | -1.12% | EXIT | |
| 9 | SG7 | Sage Therapeutics Inc | Stock-Other | 3.70% | — | +35.72% | |
| 10 | LKFT | Lakefront Biotherapeutic-adr | Stock-Other | 3.51% | +1.23% | — | |
| 11 | MAGN | Magnera CORP | Stock-Other | 2.70% | — | — | |
| 12 | STGW | Stagwell Inc | Stock-Other | 2.41% | +0.37% | +12.13% | |
| 13 | KROS | Keros Therapeutics Inc | Stock-Other | 2.40% | -0.01% | — | |
| 14 | INVX | Innovex International Inc | Stock-Other | 1.84% | — | -26.75% | |
| 15 | MRP | Millrose Properties | Stock-Real Estate | 1.57% | +0.39% | NEW | |
| 16 | NNI | Nelnet Inc-cl A | Stock-Other | 1.17% | — | -38.33% | |
| 17 | CRGX | Cargo Therapeutics Inc | Stock-Other | 1.15% | — | +4054.08% | |
| 18 | CNNE | Cannae Holdings Inc | Stock-Other | 0.94% | — | +60.92% | |
| 19 | AIV | Apartment Invt & Mgmt Co -a | Stock-Other | 0.85% | -0.61% | — | |
| 20 | ALMS | Alumis Inc | Stock-Other | 0.37% | — | — | |
| 21 | FSP | Franklin Street Properties C | Stock-Other | 0.28% | -0.03% | EXIT | |
| 22 | ARVN | Arvinas Inc | Stock-Other | 0.25% | — | — | |
| 23 | PLRX | Pliant Therapeutics Inc | Stock-Other | 0.17% | — | +33.13% | |
| 24 | CMCO | Columbus Mckinnon Corp/ny | Stock-Other | 0.05% | — | -92.58% | |
| 25 | SN | SharkNinja, Inc. | Stock-Consumer Disc | 0.04% | -0.03% | EXIT | |
| 26 | OVID | Ovid Therapeutics Inc | Stock-Other | 0.03% | — | -46.81% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SNDK | Sandisk CORP | +10.8% | NEW | New buy |
| 2 | GMED | Globus Medical Inc - A | +6.8% | NEW | New buy |
| 3 | LKFT | Lakefront Biotherapeutic-adr | +3.5% | NEW | New buy |
| 4 | KROS | Keros Therapeutics Inc | +2.4% | NEW | New buy |
| 5 | MRP | Millrose Properties | +1.6% | NEW | New buy |
| 6 | INDV | Indivior Pharmaceuticals, Inc. | +1.5% | +1.67% | Add |
| 7 | CRGX | Cargo Therapeutics Inc | +1.1% | +4054.08% | Add |
| 8 | AIV | Apartment Invt & Mgmt Co -a | +0.9% | NEW | New buy |
| 9 | SG7 | Sage Therapeutics Inc | +0.7% | +35.72% | Add |
| 10 | ALMS | Alumis Inc | +0.4% | NEW | New buy |
| 11 | CNNE | Cannae Holdings Inc | +0.3% | +60.92% | Add |
| 12 | ARVN | Arvinas Inc | +0.3% | NEW | New buy |
| 13 | SN | SharkNinja, Inc. | — | — | Unchanged |
| 14 | PLRX | Pliant Therapeutics Inc | 0% | +33.13% | Add |
| 15 | ACHC | Acadia Healthcare Co Inc | 0% | EXIT | Sold out |
| 16 | OVID | Ovid Therapeutics Inc | 0% | -46.81% | Trim |
| 17 | FSP | Franklin Street Properties C | -0.1% | -5.60% | Trim |
| 18 | TBPH | Theravance Biopharma, Inc. | -0.2% | — | Unchanged |
| 19 | TSVT* | 2seventy Bio Inc | -0.2% | EXIT | Sold out |
| 20 | CMCO | Columbus Mckinnon Corp/ny | -0.8% | -92.58% | Trim |
| 21 | ✓ | Acelyrin Inc | -0.9% | EXIT | Sold out |
| 22 | NNI | Nelnet Inc-cl A | -1% | -38.33% | Trim |
| 23 | STGW | Stagwell Inc | -1.3% | +12.13% | Add |
| 24 | INVX | Innovex International Inc | -1.8% | -26.75% | Trim |
| 25 | WLY | Wiley (john) & Sons-class A | -2.2% | -7.04% | Trim |
| 26 | MAGN | Magnera CORP | -2.5% | — | Unchanged |
| 27 | MKL | Markel Group Inc | -3.3% | -7.71% | Trim |
| 28 | PCG | P G & E CORP | -4.3% | EXIT | Sold out |
| 29 | GHC | Graham Holdings Co-class B | -4.5% | — | Unchanged |
| 30 | SOLV | Solventum CORP | -6.8% | -20.22% | Trim |
According to official SEC Form 13F filings, Madison Avenue Partners, LP reported a total U.S. public equity portfolio value of $2.3B across 26 disclosed positions in Q2 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including GHC, SOLV, MKL) accounted for 36.6% of total reported equity market value during Q2 2025.
Top New Position Initiated
SNDK
市值: $161.9M
Top Position Liquidated / Trimmed
PCG
前期市值: $50.7M
During Q2 2025, Madison Avenue Partners, LP's top holdings by market value included GHC (15.5%)、SOLV (11.4%)、MKL (11.2%). The largest single position, GHC, represented 15.5% of total portfolio value.
In Q2 2025, Madison Avenue Partners, LP made 26 total portfolio adjustments, initiating 8 new buys, adding to 6 positions, trimming 8 holdings, and fully liquidating 4 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.